Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc Analysis

BACKGROUND: The Combination Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus (CAMERA2) trial ceased recruitment in July 2018, noting that a higher proportion of patients in the intervention arm (combination therapy) developed acute kidney injury (AKI) compared to the standard thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Legg, Amy, Roberts, Matthew A, Davies, Jane, Cass, Alan, Meagher, Niamh, Sud, Archana, Daitch, Vered, Dishon Benattar, Yael, Yahav, Dafna, Paul, Mical, Xinxin, Chen, Ping, Yeo He, Lye, David, Lee, Russel, Robinson, J Owen, Foo, Hong, Tramontana, Adrian R, Bak, Narin, Grenfell, Adelaide, Rogers, Benjamin, Li, Ying, Joshi, Neela, O’Sullivan, Matthew, McKew, Genevieve, Ghosh, Niladri, Schneider, Kellie, Holmes, Natasha E, Dotel, Ravindra, Chia, Timothy, Archuleta, Sophia, Smith, Simon, Warner, Morgyn S, Titin, Christina, Kalimuddin, Shirin, Roberts, Jason A, Tong, Steven Y C, Davis, Joshua S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368200/
https://www.ncbi.nlm.nih.gov/pubmed/37496601
http://dx.doi.org/10.1093/ofid/ofad337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368200/
https://www.ncbi.nlm.nih.gov/pubmed/37496601
http://dx.doi.org/10.1093/ofid/ofad337

Ejemplares similares